Stay updated on PLACARD Trial: CXD101 + Pembrolizumab in DLBCL

Sign up to get notified when there's something new on the PLACARD Trial: CXD101 + Pembrolizumab in DLBCL page.
Latest website image capture
Clouds background image

Latest updates to the PLACARD Trial: CXD101 + Pembrolizumab in DLBCL page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Footer updated to display Revision: v3.3.3; HHS Vulnerability Disclosure and Revision: v3.3.2 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T07:53:02.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Revision: v3.3.2 is displayed, replacing v3.3.1. No substantive study information appears to have changed.
    Difference
    0.1%
    Check dated 2025-12-01T15:11:46.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Revision: v3.3.1 was added and Revision: v3.2.0 was removed, a metadata update with no change to trial content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T11:01:19.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The government funding/operating status notice was removed from the page. This does not affect the study details, eligibility criteria, or trial timelines.
    Difference
    0.4%
    Check dated 2025-11-17T06:08:07.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    Both screenshots show the same study details and status; there are no additions or deletions to core content such as the trial title, conditions, eligibility, or outcomes.
    Difference
    0.4%
    Check dated 2025-11-03T00:45:03.000Z thumbnail image
  9. Check
    104 days ago
    Change Detected
    Summary
    Core page content updated with a government operating status notice and a new resource topic; software revision updated from v3.1.0 to v3.2.0. No other significant changes.
    Difference
    3%
    Check dated 2025-10-05T06:34:39.000Z thumbnail image

Stay in the know with updates to PLACARD Trial: CXD101 + Pembrolizumab in DLBCL

Enter your email address, and we'll notify you when there's something new on the PLACARD Trial: CXD101 + Pembrolizumab in DLBCL page.